• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性醛固酮增多症中醛固酮:肾素比值的患者内可重复性。

Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.

机构信息

DMCS-Internal Medicine 4, University Hospital, Via Giustiniani 2, 35126 Padova, Italy.

出版信息

Hypertension. 2010 Jan;55(1):83-9. doi: 10.1161/HYPERTENSIONAHA.109.139832. Epub 2009 Nov 23.

DOI:10.1161/HYPERTENSIONAHA.109.139832
PMID:19933925
Abstract

The plasma aldosterone concentration:renin ratio (ARR) is widely used for the screening of primary aldosteronism, but its reproducibility is unknown. We, therefore, investigated the within-patient reproducibility of the ARR in a prospective multicenter study of consecutive hypertensive patients referred to specialized centers for hypertension in Italy. After the patients were carefully prepared from the pharmacological standpoint, the ARR was determined at baseline in 1136 patients and repeated after, on average, 4 weeks in the patients who had initially an ARR > or =40 and in 1 of every 4 of those with an ARR <40. The reproducibility of the ARR was assessed with Passing and Bablok and Deming regression, coefficient of reproducibility, and Bland-Altman and Mountain plots. Within-patient ARR comparison was available in 268 patients, of whom 49 had an aldosterone-producing adenoma, on the basis of the "4-corner criteria." The ARR showed a highly significant within-patient correlation (r=0.69; P<0.0001) and reproducibility. Bland-Altman plot showed no proportional, magnitude-related, or absolute systematic error between the ARR; moreover, only 7% of the values, for example, slightly more than what could be expected by chance, fell out of the 95% CI for the between-test difference. The accuracy of each ARR for pinpointing aldosterone-producing adenoma patients was approximately 80%. Thus, although it was performed under different conditions in a multicenter study, the ARR showed a good within-patient reproducibility. Hence, contrary to previously claimed poor reproducibility of the ARR, these data support its use for the screening of primary aldosteronism.

摘要

血浆醛固酮浓度

肾素比值(ARR)广泛用于原发性醛固酮增多症的筛查,但尚不清楚其可重复性。因此,我们在意大利专门的高血压中心对连续高血压患者进行了前瞻性多中心研究,以调查 ARR 的患者内可重复性。在从药理学角度仔细准备患者后,在 1136 例患者中确定了 ARR 的基线值,并在最初 ARR≥40 的患者中平均 4 周后重复测量,在 ARR<40 的患者中每 4 例中重复测量 1 例。ARR 的可重复性采用 Passing 和 Bablok 以及 Deming 回归、重复性系数、Bland-Altman 和 Mountain 图进行评估。在 268 例患者中可进行患者内 ARR 比较,其中 49 例基于“四角标准”患有醛固酮分泌瘤。ARR 显示出高度显著的患者内相关性(r=0.69;P<0.0001)和可重复性。Bland-Altman 图显示 ARR 之间没有比例、大小相关或绝对系统误差;此外,只有 7%的数值,例如略高于可能出现的随机值,超出了两次测试差异的 95%置信区间。ARR 确定醛固酮分泌瘤患者的准确性约为 80%。因此,尽管在多中心研究中在不同条件下进行,但 ARR 显示出良好的患者内可重复性。因此,与之前声称的 ARR 可重复性差相反,这些数据支持其用于原发性醛固酮增多症的筛查。

相似文献

1
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.原发性醛固酮增多症中醛固酮:肾素比值的患者内可重复性。
Hypertension. 2010 Jan;55(1):83-9. doi: 10.1161/HYPERTENSIONAHA.109.139832. Epub 2009 Nov 23.
2
Test characteristics of the aldosterone-to-renin ratio as a screening test for primary aldosteronism.醛固酮与肾素比值作为原发性醛固酮增多症筛查试验的检测特征。
J Hypertens. 2014 Jan;32(1):115-26. doi: 10.1097/HJH.0b013e3283656b54.
3
The cutoff value of aldosterone-to-renin ratio for the diagnosis of primary aldosteronism in patients taking antihypertensive medicine.服用抗高血压药物患者原发性醛固酮增多症诊断中醛固酮与肾素比值的临界值。
Clin Exp Hypertens. 2008 Oct;30(7):640-7. doi: 10.1080/10641960802443282.
4
Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma.盐水输注试验对排除因醛固酮分泌性腺瘤导致的原发性醛固酮增多症的前瞻性评估。
J Hypertens. 2007 Jul;25(7):1433-42. doi: 10.1097/HJH.0b013e328126856e.
5
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.醛固酮-肾素比值检测醛固酮瘤的定量价值:原发性醛固酮增多症醛固酮-肾素比值(AQUARR)研究
J Am Heart Assoc. 2017 May 21;6(5):e005574. doi: 10.1161/JAHA.117.005574.
6
[Aldosterone-to-renin ratio threshold for screening primary aldosteronism in Chinese hypertensive patients].[中国高血压患者原发性醛固酮增多症筛查的醛固酮与肾素比值阈值]
Zhonghua Xin Xue Guan Bing Za Zhi. 2006 Oct;34(10):868-72.
7
Aldosterone-to-renin ratio acts as the predictor distinguishing the primary aldosteronism from chronic kidney disease.醛固酮与肾素比值可作为区分原发性醛固酮增多症与慢性肾脏病的预测指标。
Int J Clin Exp Pathol. 2015 Jun 1;8(6):6901-9. eCollection 2015.
8
Assessment of the Quantitative Value Usefulness of the Aldosterone-Renin Ratio (ARR) for Primary Aldosteronism (AQUARR) Study.原发性醛固酮增多症中醛固酮-肾素比值(ARR)定量值实用性评估(AQUARR)研究
High Blood Press Cardiovasc Prev. 2016 Mar;23(1):19-23. doi: 10.1007/s40292-015-0125-0. Epub 2015 Dec 16.
9
Screening for primary aldosteronism in an argentinian population: a multicenter prospective study.阿根廷人群原发性醛固酮增多症的筛查:一项多中心前瞻性研究。
Arch Endocrinol Metab. 2015 Oct;59(5):441-7. doi: 10.1590/2359-3997000000075. Epub 2015 Jul 24.
10
Analysis of screening and confirmatory tests in the diagnosis of primary aldosteronism: need for a standardized protocol.原发性醛固酮增多症诊断中筛查和确诊试验的分析:需要标准化方案。
J Hypertens. 2006 Apr;24(4):737-45. doi: 10.1097/01.hjh.0000217857.20241.0f.

引用本文的文献

1
Shifting paradigms in primary aldosteronism: reconsideration of screening strategy via integrating pathophysiological insights.原发性醛固酮增多症的范式转变:通过整合病理生理学见解重新考虑筛查策略
Front Endocrinol (Lausanne). 2025 Jan 14;15:1372683. doi: 10.3389/fendo.2024.1372683. eCollection 2024.
2
Captopril challenge test in the diagnosis of primary aldosteronism: consistency between 1- and 2- h sampling.卡托普利激发试验在原发性醛固酮增多症诊断中的应用:1 小时和 2 小时采样的一致性。
Front Endocrinol (Lausanne). 2023 Jun 12;14:1183161. doi: 10.3389/fendo.2023.1183161. eCollection 2023.
3
The Effect of Antihypertensive Medications on Testing for Primary Aldosteronism.
抗高血压药物对原发性醛固酮增多症检测的影响
Front Pharmacol. 2021 May 13;12:684111. doi: 10.3389/fphar.2021.684111. eCollection 2021.
4
The 2020 Italian Society of Arterial Hypertension (SIIA) practical guidelines for the management of primary aldosteronism.2020年意大利动脉高血压学会(SIIA)原发性醛固酮增多症管理实用指南。
Int J Cardiol Hypertens. 2020 Apr 15;5:100029. doi: 10.1016/j.ijchy.2020.100029. eCollection 2020 Jun.
5
Confounders of the aldosterone-to-renin ratio when used as a screening test in hypertensive patients: A critical analysis of the literature.作为高血压患者筛查试验时,醛固酮与肾素比值的混杂因素:文献批判性分析。
J Clin Hypertens (Greenwich). 2021 Feb;23(2):201-207. doi: 10.1111/jch.14117. Epub 2020 Dec 27.
6
Repeat Adrenal Vein Sampling in Aldosteronism: Reproducibility and Interpretation of Persistently Discordant Results.醛固酮增多症患者重复肾上腺静脉采样:结果持续不一致的可重复性和解读。
J Clin Endocrinol Metab. 2021 Mar 8;106(3):e1170-e1178. doi: 10.1210/clinem/dgaa930.
7
Diagnostic Accuracy of the Aldosterone-to-Active Renin Ratio for Detecting Primary Aldosteronism.醛固酮与活性肾素比值检测原发性醛固酮增多症的诊断准确性
J Endocr Soc. 2019 Jul 19;3(9):1748-1758. doi: 10.1210/js.2019-00145. eCollection 2019 Sep 1.
8
Effects of mineralocorticoid and AT-1 receptor antagonism on the aldosterone-renin ratio (ARR) in primary aldosteronism patients (EMIRA Study): rationale and design.醛固酮-肾素比值(ARR)在原发性醛固酮增多症患者中对盐皮质激素和 AT1 受体拮抗剂的影响(EMIRA 研究):原理和设计。
J Hum Hypertens. 2019 Feb;33(2):167-171. doi: 10.1038/s41371-018-0139-x. Epub 2018 Dec 5.
9
Quantitative Value of Aldosterone-Renin Ratio for Detection of Aldosterone-Producing Adenoma: The Aldosterone-Renin Ratio for Primary Aldosteronism (AQUARR) Study.醛固酮-肾素比值检测醛固酮瘤的定量价值:原发性醛固酮增多症醛固酮-肾素比值(AQUARR)研究
J Am Heart Assoc. 2017 May 21;6(5):e005574. doi: 10.1161/JAHA.117.005574.
10
The Aldosterone Renin Ratio (ARR) APP as Tool to Enhance the Detection Rate of Primary Aldosteronism.醛固酮肾素比值(ARR)应用程序作为提高原发性醛固酮增多症检出率的工具。
High Blood Press Cardiovasc Prev. 2016 Jun;23(2):147-9. doi: 10.1007/s40292-016-0132-9. Epub 2016 Feb 16.